Scout | NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

This opportunity is no longer accepting applications.

grant

NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)

This grant opportunity invites small businesses to apply for funding to conduct exploratory clinical trials on investigational drugs, biologics, surgical therapies, or devices. These trials should help gather necessary data and justification for designing larger clinical studies. The diseases selected for study should align with the NINDS strategic plan and clinical research focus areas.

Source

Agency: National Institutes of Health

Program: SBIR

Award

Award Ceiling: $1M

Funding Amount: $1M

Dates

Opportunity Released: May 5, 2021

Open for Submission: May 5, 2021

Submission Deadline: September 5, 2024

Application Window Closes: September 5, 2024

Keywords

NeuroNEXT

Small Business Innovation

Clinical Trials

Exploratory Trials

Investigational Agents

Drug Development

Biologics

Surgical Therapies

Medical Devices

NINDS Strategic Plan

Supporting Links

Documents

Similar Opportunities

Unlock similar opportunities

Get the full picture on this opportunity

Create a free Scout account to unlock everything you need to decide fast and win the grant.

Instant Fit Analysis

Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
Deep agency & funder detail

Program context, sub-agency structure, and a full eligibility breakdown.
Source links & full documents

Jump straight to the solicitation and download every attachment.
Similar opportunities

Discover related funding matched to your work.

Get a Demo Sign Up

Already have an account? Sign In

Trusted by 500+ Happy Customers